1. AstraZeneca Director Pushing to Tie Exec Pay to Big Growth Promises

    AstraZeneca Director Pushing to Tie Exec Pay to Big Growth Promises

    Soriot and his team fought hard against Pfizer's £55-per-share bid, and in the process promised to send sales soaring to $45 billion by 2023. Last summer, some top shareholders suggested directly linking executive pay to progress toward those goals. And in ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. We're concerned the management get paid out because the share price has gone up, and actually they don't deliver anything to justify these forward-looking revenue targets.
  3. Topics Mentioned